Vitafol-ob Plus Dha Kit
NDC Package 0642-0076-30
Package Information
Vitafol-ob Plus Dha (vitamin a, ascorbic acid, vitamin d, .alpha.-tocopherol, thiamine mononitrate, riboflavin, niacin, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium, iron, magnesium, zinc, copper, and doconexent) kits is vitafol®-OB+DHA is indicated to provide vitamin, mineral and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother including individuals with known allergies to fish. This formulation utilizes a kit delivery system. Marketed by Exeltis Usa, Inc, this product is identified by NDC 0642-0076.
Identification & Billing
- RxCUI: 1100198 - docosahexaenoic acid 250 MG Oral Capsule
- RxCUI: 1100198 - DHA 250 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0642 - Exeltis Usa, Inc
- 0642-0076 - Vitafol-ob Plus Dha
- 0642-0076-30 - 1 KIT in 1 CARTON * 30 TABLET, COATED in 1 BOX * 30 CAPSULE in 1 BOX
- 0642-0076 - Vitafol-ob Plus Dha
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0642-0076). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0642-0076-30 identifies a specific commercial package of 1 kit in 1 carton * 30 tablet, coated in 1 box * 30 capsule in 1 box of Vitafol-ob Plus Dha Prenatal Supplement Plus Dha, a human prescription drug labeled by Exeltis Usa, Inc. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Exeltis Usa, Inc on February 16, 2007. The current certification is valid through December 31, 2026.
How is this Exeltis Usa, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00642007630. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.